Brian Schmitt - Auxly Cannabis Chief Officer
| CBWTF Stock | USD 0.03 0 8.00% |
Executive
Mr. Brian William Schmitt is Chief Financial Officer of the company. Mr. Brian Schmitt, CFO, is an accomplished finance and accounting executive with approximately 30 years of experience in both private and publiclytraded companies. Most recently, Mr. Schmitt acted as the CFO at EnerCare Inc., where during his tenure with the company he played a large part in growing the company through acquisition and helped carve out their strategy, systems integration and operating plan. He also served as Vice President Planning Administration for Wells Fargo Financial and held senior finance and accounting roles with Citi Financial and Ernst Young since 2019.
| Tenure | 5 years |
| Professional Marks | CPA |
| Phone | 647 812 0121 |
| Web | https://auxly.com |
Brian Schmitt Latest Insider Activity
Tracking and analyzing the buying and selling activities of Brian Schmitt against Auxly Cannabis otc stock is an integral part of due diligence when investing in Auxly Cannabis. Brian Schmitt insider activity provides valuable insight into whether Auxly Cannabis is net buyers or sellers over its current business cycle. Note, Auxly Cannabis insiders must abide by specific rules, including filing SEC forms every time they buy or sell Auxly Cannabis'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Brian Schmitt over a year ago Acquisition by Brian Schmitt of 1500 shares of Colony Bankcorp subject to Rule 16b-3 | ||
Brian Schmitt over a year ago Payment of 951 shares by Brian Schmitt of Colony Bankcorp subject to Rule 16b-3 |
Auxly Cannabis Management Efficiency
The company has return on total asset (ROA) of (0.0868) % which means that it has lost $0.0868 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.806) %, meaning that it generated substantial loss on money invested by shareholders. Auxly Cannabis' management efficiency ratios could be used to measure how well Auxly Cannabis manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | EXECUTIVE Age | ||
| Andrew Grossman | Green Thumb Industries | 49 | |
Management Performance
| Return On Equity | -0.81 | |||
| Return On Asset | -0.0868 |
Auxly Cannabis Group Leadership Team
Elected by the shareholders, the Auxly Cannabis' board of directors comprises two types of representatives: Auxly Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Auxly. The board's role is to monitor Auxly Cannabis' management team and ensure that shareholders' interests are well served. Auxly Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Auxly Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ian Rapsey, Chief Officer | ||
| Ron Fichter, Gen Sec | ||
| Hugo Alves, President Director | ||
| Vladimir Klacar, VP Planning | ||
| Alan Cooke, VP Operations | ||
| Brian Schmitt, Chief Officer | ||
| Kevin Furet, Chief Officer | ||
| Carla Nawrocki, Vice President of Investor Relations | ||
| Andrew MacMillan, Vice President Commercial Business Development | ||
| Michael Lickver, President |
Auxly Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Auxly Cannabis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.81 | |||
| Return On Asset | -0.0868 | |||
| Profit Margin | (1.34) % | |||
| Operating Margin | (0.52) % | |||
| Current Valuation | 146.85 M | |||
| Shares Outstanding | 913.01 M | |||
| Shares Owned By Insiders | 21.04 % | |||
| Shares Owned By Institutions | 3.18 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 0.16 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Auxly OTC Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.